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ABSTRACT Recent molecular-dynamics simulations have suggested that the arginine-rich HIV Tat peptides translocate by
destabilizing and inducing transient pores in phospholipid bilayers. In this pathway for peptide translocation, Arg residues
play a fundamental role not only in the binding of the peptide to the surface of the membrane, but also in the destabilization
and nucleation of transient pores across the bilayer. Here we present a molecular-dynamics simulation of a peptide composed
of nine Args (Arg-9) that shows that this peptide follows the same translocation pathway previously found for the Tat peptide. We
test experimentally the hypothesis that transient pores open by measuring ionic currents across phospholipid bilayers and cell
membranes through the pores induced by Arg-9 peptides. We ﬁnd that Arg-9 peptides, in the presence of an electrostatic poten-
tial gradient, induce ionic currents across planar phospholipid bilayers, as well as in cultured osteosarcoma cells and human
smooth muscle cells. Our results suggest that the mechanism of action of Arg-9 peptides involves the creation of transient pores
in lipid bilayers and cell membranes.INTRODUCTION
Cell-penetrating peptides (CPPs) are short sequences of
amino acids (<30) that are capable of entering most mamma-
lian cells. CPPs have the special property of carrying with
them cargoes of a wide range of molecular sizes, such as
proteins, oligonucleotides, and even 200 nm liposomes
(1–7). Many CPPs are highly cationic and hydrophilic, and
exhibit no or relatively low amphipathicity when compared
with other peptides that are known to interact with and per-
meabilize phospholipid membranes. The translocation
mechanism by which these peptides are able to enter cells
has remained elusive since they were first discovered
(1,2,8,9). There is ample evidence suggesting that the uptake
is independent of metabolic energy and does not involve any
specific cell receptor (2). Other reports indicate that the
uptake may involve lipid raft-mediated endocytotic path-
ways (10–12). Even when the uptake initially follows an
endocytotic pathway, arg-rich CPPs are still able to breach
the endosome membrane barrier to reach, for example, the
cell nucleus (13).
A common feature of cationic CPPs is that they form
a rapid and tight interaction with extracellular glycosamino-
glycans, such as heparan sulfate, heparin, and chondroitin
sulfate B (13). However, whereas a significant part of the
uptake of CPPs might involve heparan sulfate receptors,
efficient internalization is observed even in their absence
(14). Furthermore, these peptides are capable of entering
giant unilamellar vesicles (GUVs) composed of model phos-
pholipid membranes (15–18). These results suggest that
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bilayer, altering its resting structure, and that these changes
facilitate peptide translocation. Taken together, these find-
ings suggest that the binding of highly cationic CPPs to
anionic plasma membrane components, such as phosphate
groups, could be an important step for effective peptide
translocation across a phospholipid bilayer or the cell
membrane.
The relevance of peptide-phosphate interactions can be
understood through a theoretical model that we recently
proposed for the translocation of the Tat peptide (19). This
model shows how these peptides may be able to nucleate
a pore and diffuse across a phospholipid bilayer. It also high-
lights the special importance of the charged amino acids in
the translocation mechanism, where the Arg and Lys side
chains initially bind to the phospholipid phosphate groups,
producing strong distortions to the bilayer relative to their
resting structure that lead to the formation of a pore. The rele-
vance of the Arg-phosphate interaction has been highlighted
in several reports indicating, for example, that poly-Arg
peptides translocate more efficiently than poly-Lys peptides
and the Tat peptide (9,20). The interaction of Arg amino
acids with phosphate groups of the plasma membrane plays
a fundamental role in other physiological processes, such
as the voltage gating of potassium ion channels (21,22). It
has been suggested that the use of Arg in voltage sensors
may be an adaptation to the phospholipid composition
of cell membranes (23). The importance of guanidinium-
phospholipid interactions has also led to intense theoretical
research (24–28).
Several Arg-rich antimicrobial peptides can also disrupt
and form pores in lipid bilayers and bacterial cell membranes
(29–31). It is known that antimicrobial peptides are able to
doi: 10.1016/j.bpj.2009.05.066
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energy-independent manner. Since CPPs also seem to be
capable of translocating in an energy-independent manner,
they could share a similar pore-opening mechanism (2,19,
32,33). However, an important difference between hydro-
philic CPPs and antimicrobial peptides is the lack of hydro-
phobic residues in the former case. It has been shown that
poly-Arg peptides composed of nine Arg amino acids (Arg-9)
are able to translocate across cells very efficiently (34).
Based on the theoretical translocation pathway found for
Tat and Arg-9, the central hypothesis of the experimental
work presented here is as follows: If Arg-rich CPPs disturb
and induce pores in phospholipid membranes, then ions
should be able to flow across lipid membranes through
these pores. Therefore, applying an electrostatic potential
should produce ionic currents through the pores induced
by CPPs across phospholipid bilayers and cell membranes.
Consistent with this hypothesis, we detected ionic currents
induced by Arg-9 on 1), model phospholipid membranes
using the planar phospholipid bilayers method (35); and
2), on freshly isolated human umbilical artery (HUA) smooth
muscle cells and on cultured osteosarcoma cells using
the patch-clamp technique (36). We found that the ionic
permeability of phospholipid bilayers and cell membranes
is increased by the presence of the Arg-9 peptides. We
also explored other peptides and solution conditions that
alter this permeability.
This work covers systems with different degrees of
complexity, ranging from simulations of very simple systems
to experiments on live mammalian cells. The molecular
dynamics (MD) studies reported previously for Tat peptides
(19) and here for Arg-9 peptides were conducted on simple
systems containing a single phospholipid (1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC)), a few peptides, and
water. Cell membranes and model membranes are usually
composed of multiple lipids (33,37) and modified lipids.
Here, we experimentally study a series of systems that are as
simple as the systems modeled computationally, systems that
contain lipid mixtures containing 1,2-Dioleoyl-sn-Glycero-
3-[Phospho-rac-(1-glycerol)] (DOPG) (e.g., 3:1 DOPC/
DOPG), and mammalian cells under different salt and pH
conditions. This allows us to present physical, chemical,
and biological details of the interactions between Arg-rich
peptides and the cell membrane that we believe are essential
to unveil the cell translocation pathway for CPPs.
MATERIALS AND METHODS
MD simulations
MD simulations were performed to study the translocation mechanism of
Arg-9 peptides across model membranes. The Arg-9 peptides were placed
in a periodically repeating box containing water molecules and a preequili-
brated lipid membrane composed of DOPC lipids (38,39). The peptides
were placed near one side of the bilayer such that the Arg-9 peptides would
bind mostly to one layer of the bilayer. These configurations are away fromBiophysical Journal 97(7) 1917–1925equilibrium. We explored how the systems relax from these configurations.
Due to periodic boundary conditions, there are two paths by which an Arg-9
peptide on one layer can move to bind the other layer: one that requires trans-
location, and one that requires detachment from a lipid layer and diffusion of
the Arg-9 peptide from the initial configuration near the water-bilayer
boundary on one layer to the other layer. Our calculations include a large
number of water molecules such that binding to the proximal layer, given
the initial conditions that we selected, is favored. We assume that the
Arg-9 peptide remains fully charged throughout the simulation, consistent
with observations describing a lack of changes in the pKa of buried Arg
side chains in the interior of proteins. Potential of mean force calculations
have shown that a single Arg side chain may adopt the protonated state in
a lipid bilayer (26,40,41). MacCallum et al. (40) found that the cost of insert-
ing a second charged amino acid side chain into a lipid bilayer is much less
than for the first, and therefore it is reasonable for us to assume that Arg-9
will remain fully charged. The total length of the simulation was 500 ns.
All simulations were performed using the GROMACS package (42). The
simulated system consists of four Arg-9 peptides, 92 DOPC phospholipid
molecules, and 8795 water molecules. More details are provided in the Sup-
porting Material.
The experimental techniques included planar lipid bilayers, with bilayers
composed of 100% DOPC and 3:1 DOPC/DOPG lipid mixtures. Patch-
clamp measurements were conducted in cultured osteosarcoma cells and
human smooth muscle cells freshly isolated from the umbilical artery. All
experiments measured currents in the presence and absence of Arg-9
peptides and DAP-9 peptides under various conditions. The experimental
methods are described in more detail in the Supporting Material.
RESULTS AND DISCUSSION
Theoretical model
We recently proposed a model for the translocation of the
HIV-1 Tat peptide based on MD simulations (19). This model
shows how these peptides are able to diffuse across phospho-
lipid bilayers. It consists of four basic steps: 1), the peptides
bind to the surface of the bilayer, attracted by the phosphate
groups of the phospholipids; 2), as the surface concentration
of peptides increases, the arrangement of lipids is strongly
distorted compared to that in the resting membrane; 3), an
Arg side chain translocates to the distal layer, nucleating the
formation of a water pore; and 4), a few peptides translocate
by diffusing on the surface of the pore and the pore closes.
This model highlights the central role of the Arg amino acids,
including their strong attachment to the phosphate groups and
their ability to induce strong distortions to the structure of
the phospholipid bilayer. It has been reported that Arg-9
peptides internalize more efficiently than Tat peptides. There-
fore, a natural question is, do peptides composed entirely of
Arg amino acids such as Arg-9 follow a translocation pathway
similar to that of the Tat peptide? In Fig. 1 are shown four
snapshots extracted from this MD simulation, in which it
can be seen that Arg-9 follows the same mechanism previ-
ously described for Tat.
During the first 50 ns the Arg-9 peptides bind to the phos-
phate groups in the proximal layer of the lipid bilayer. The
guanidinium groups of the Arg side chains make hydrogen-
bond contacts with various oxygen atoms of the lipid head-
groups, and the peptide is partially immersed into the bilayer
at the level of the glycerol groups. After 100 ns an Arg side
Permeabilization by Arg-Rich Peptides 1919chain is attracted to a phosphate group in the distal layer of the
bilayer. This phosphate group and the Arg side chain carry
some water molecules with them, so they are never fully
desolvated. During this period of time, a water chain crossing
the bilayer is formed and a toroidal pore is nucleated. One of
the Arg-9 peptides translocates by diffusing on the surface
of the pore. In this calculation, the toroidal pore remains
open toward the end of 500 ns. We speculate that the complete
translocation of a peptide and closing of the pore will occur on
the microsecond timescale; however, this was not explored in
our calculations. The radius of the toroidal pore varies in size,
having a maximum diameter of 2.5 nm. The pore surface is
lined up with phosphate headgroups. The mechanism of
Arg side-chain insertion and pore formation observed in the
calculations with Arg-9 is identical to the mechanism found
for the Tat peptide (19).
The destabilization of lipid membranes and the formation
of pores induced by these peptides should lead to an increase
in the ionic permeability of phospholipid bilayers and the
cell membrane. To validate this prediction of the model,
we experimentally investigated the permeabilizing effects
of Arg-9 in planar lipid membranes and mammalian cells
using two electrophysiological setups as described below.
FIGURE 1 Four snapshots of an MD simulation. (a) Lateral view
showing how the peptides are bound to the membrane before translocation.
(b) Translocation of an Arg amino acid surrounded by water molecules that
nucleates the formation of a water pore. (c) Lateral view of the pore, trans-
located peptide surrounded by a dotted square line, and a translocating
peptide circled by an oval dotted line. (d) Top view of the pore. The phos-
pholipid molecules are represented with transparent white surfaces, the
phosphate atoms are in yellow spheres, the peptide molecules are in red,
any water molecule at a distance of <0.35 nm from any phospholipids or
amino acid atom is colored in solid blue, and the rest of the water molecules
appear as a transparent blue surface.Permeabilization of model lipid membranes
If CPPs are able to destabilize phospholipid bilayers,
producing transient pores across them, then ionic permeabi-
lization should be observed. To test this hypothesis on model
lipid membranes, we made phospholipid bilayers using the
planar lipid bilayer (also known as the black lipid membrane)
method (35). The basic idea of this setup is described in
Fig. S1. The addition of micromolar concentrations of Arg-9
to the aqueous solution bathing a planar bilayer membrane
led to an increase of membrane conductance in all experi-
ments (>50 experiments). Fig. 2 a shows the permeabiliza-
tion of a phospholipid bilayer composed of a lipid mixture
of DOPC/DOPG (3:1) after the addition of Arg-9 at a concen-
tration of 7 mM to the cis chamber. After the peptide is added
to the cis chamber, the ionic permeabilization across the
membrane increases. A similar effect is shown in Fig. 2 c
for bilayers composed entirely of DOPC phospholipid
molecules. This proves that anionic phospholipids such as
DOPG are not strictly required for peptide permeabilization
of the bilayer, since the peptides are still able to interact and
permeabilize purely zwitterionic DOPC phospholipid bila-
yers. The permeabilization increases both continuously and
with discrete jumps. The recordings show that the perme-
ability increases and reduces several times until finally the
membrane breaks permanently. The transient current spikes
were quite abrupt and most of the time did not resemble
recordings of well-defined ionic channels, such as voltage-
dependent ion channels.
FIGURE 2 Permeabilization of phospholipid bilayers composed of a lipid
mixture of DOPC/DOPG (3:1) (a and b) after the addition of 7mM of Arg-9
to the cis chamber, (c) phospholipid bilayer composed entirely of DOPC, (d)
lipid mixture of DOPC/DOPG (the CaCl2 ions are added to the solution
before the addition of the peptide), (e) control measurement on a lipid
mixture of DOPC/DOPG with addition of the Dap-9 peptide, and (f) control
measurement on a lipid mixture of DOPC/DOPG without peptides. The
arrow’s origin indicates the time at which the peptides or CaCl2 were added
to the solution. The potential of the cis chamber relative to the trans chamber
(the holding potential) is 50 mV. The ionic concentration is 100 mM of KCl
and the pH is 7.4.Biophysical Journal 97(7) 1917–1925
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expected to displace the Arg amino acids or screen the under-
lying membrane phosphate groups. The permeability of the
plasma membrane produced by the peptides should therefore
be reduced upon the addition of calcium chloride. Indeed, as
shown in Fig. 2 b, when calcium chloride was added to the
solution, the permeabilization of the membrane reduced to a
low baseline level. Moreover, as shown in Fig. 2 d, when the
peptides were added after the addition of 100 mM of CaCl2
to the solution, there was no increase in the permeability of
the bilayer, consistent with the ability of the Ca2þ ions to
mask the phosphate groups from the peptides. This finding
highlights the importance of electrostatic interactions in the
initiation of pore formation.
We expect Dap-9 to represent a reasonable negative
control peptide. There is substantial experimental evidence
indicating that poly-Lys CPPs translocate much less effi-
ciently than poly-Arg CPPs. The MD simulations also
suggest that reducing the length of the amino acid side chain
will diminish the efficiency of the peptide translocation.
Therefore, we tested the effect of Dap-9 (composed of nine
2,3-diaminopropanoic acid residues (Fig. S3)), which has
the same charge as Arg-9 but much shorter side chains and
amine groups instead of guanidinium groups. As shown in
Fig. 2 e, Dap-9 does not permeabilize the phospholipid
membrane. We also performed a negative control (Fig. 2 f)
using the same solution but with no peptide addition, and
no current increase was observed.
Fig. 3 a shows the current induced by Arg-9 across the
bilayer for a system with the same composition and held at
the same voltage as in Fig. 2 a. Fig. 3, b and c, show the
dependence of the current on the voltage. Each interval char-
acterizes a common state observed during the permeabiliza-
tion of the membrane: control I/V represents a controlBiophysical Journal 97(7) 1917–1925measurement before the peptide is added, I/V (i) is a measure-
ment after the addition of the peptide but before the steady
increase of the conductance across the bilayer, and I/V (ii)
is a measurement during the steady increase of conductance
across the lipid bilayer. As shown in the figure, current fluc-
tuations were seen initially after the peptides were added, but
the baseline current remained unchanged and there was no
significant difference in the average current versus voltage
recorded (Fig. 3 b, I/V (i)) compared to the same measure-
ment obtained before addition of the peptides (Fig. 3 b, I/V
control). However, after a few minutes the permeabilization
became permanent (the current baseline increased) and there
was a marked increase in slope of the current versus voltage
for I/V (ii) relative to that for control I/V. In Fig. 3, a and c,
it can be seen that after the addition of 100 mM of CaCl2,
the permeability decreased. Furthermore, after a period of
>100 min, the permeability dropped to very low baseline
values, as can be seen in Fig. 3 c, I/V (iv).
These results can be interpreted in the following way:
After the peptides are added to the solution, they start to
bind the bilayer, creating isolated local transient pores across
the bilayer. Consequently, the current baseline initially
remains at the same level as that before addition of Arg-9.
The slope of the current versus voltage plot in I/V (i) remains
almost unchanged compared to that for the I/V control, indi-
cating that the permeability increases transiently while the
baseline remains unchanged most of the time. After a few
minutes, the surface density of membrane-bound peptides
increases, destabilizing the membrane more strongly and
permanently, as reflected by the increase in the baseline
current at I/V (ii) and by the increase in the slope of the
current versus voltage. After the addition of CaCl2, the
permeability decreases, indicating that Ca2þ ions may be
competing for phosphate groups and displacing the Arg-9FIGURE 3 Current across a planar lipid bilayer under
the same conditions as in Fig. 2, c and d. (a) An average
over 10 measurements of current as a function of voltage
that were carried out at six different time points: (I/V
control) before adding the peptides, (I/V (i)) 10 min after
adding the peptide, (I/V (ii)) 40 min after adding the
peptide, (I/V (iii)) 30 min after adding CaCl2, and (I/V
(iv)) 70 min after adding CaCl2. The inset pictures show
amplified sections of the current trace; the scaled time frac-
tion is enclosed by a dotted square, and when time and
current are both scaled, the scale is included in the inset
picture. (b and c) Average current as a function of voltage.
The voltage is incremented by 10 mV between 90 mV to
90 mv and the potential is held for 150 ms at each voltage.
The points in b and c are the average over 10 consecutive
measurements taken at each of the intervals indicated in a.
It can be seen that after the peptide is added, there are
currents jumps before (I/V (i)), but there is not much differ-
ence in average between I/V control and (I/V (i)). However,
after the permeabilization becomes permanent and the
baseline current starts to increase, there is a marked
increase in the slope of the current versus voltage (I/V (ii)) relative to the control I/V (I/V control). After addition of CaCl2, the ionic permeabilization reduces.
In the last I/V record (I/V (iv)), the current is even lower than the control current. This indicates that CaCl2 reduces the permeability of the membrane to
essentially zero.
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the resealing of the phospholipid bilayer.
The insets of Figs. 3 and 4 show amplified current traces.
One can see discrete current jumps that resemble the
behavior of ion channels in cells, and rapidly fluctuating
current jumps that can be clearly distinguished from most
ionic channels. The latter types of signals can be used as
a footprint to recognize the peptide interaction with the cell
membrane, in addition to the expected steady permeabiliza-
tion increment with time.
Our measurements show that most of the time the current
fluctuates rapidly; however, in some cases, more stable
current jumps that resemble ion channels can be observed.
If we assume that these jumps are associated with the forma-
tion of stable pores across the membrane, we can estimate the
average radius of these pores by measuring the conductance.
To characterize this behavior, we show in Fig. S4 a histogram
of the amplitude of those current jumps over 118 events.
Assuming that the pore conductivity is equal to that of
100 mM of KCl, we can calculate the pore radius for a
conductance G of 4.6 pA/50 mV ¼ 0.92 1010 S using
s ¼ Gh/A, where s is the conductivity (~1.6 S m1), A is
the area of the pore, G is the conductance (~0.92 1010 S),
and h is the membrane thickness (~6 nm). The estimated
pore diameter for this current value is d ~ 2 O(Gh/sp) ¼
0.66 nm, which compares well with the pore diameter
observed in the simulations.
FIGURE 4 Fractions of current traces after the addition of 7mM of Arg-9
to the cis chamber as the time progresses. The planar lipid bilayer is
composed of a lipid mixture of DOPC/DOPG (3:1). It can be seen that as
the time increases, the permeabilization has a noisier trend.Although Arg-9 is the focus of this experimental work, we
are currently investigating the effects of Tat, penetratin, and
PG-1. Tat is also a highly hydrophilic CPP, penetratin is a
slightly amphiphilic CPP, and PG1 is a pore-forming, Arg-
rich, amphiphilic antimicrobial peptide. We also observed
in all these cases an increase in the permeabilization of the
phospholipid bilayers upon addition to a final concentration
of 7 mM (Fig. S5).
Permeability across mammalian cells
The results obtained in lipid bilayers encouraged us to test the
peptide’s effects on cell membranes of human smooth muscle
cells and osteosarcoma cells, although these systems are
structurally and functionally much more complex. To accom-
plish this task, we used the patch-clamp technique in different
configurations (whole-cell, cell-attached, and inside-out, as
described in the Supporting Material) to measure ionic
currents induced by the peptide on the cell membrane.
Whole cell: global permeabilization of the cell
We studied the effects of Arg-9 on isolated HUA smooth
muscle cells in the whole-cell configuration (Fig. S2). Fig. 5
a shows a typical time course of the current at 50 mV,
where we see that the addition of the peptide caused a slow
increased in the magnitude of this inward current. The effects
of both concentrations of Arg-9 varied among the cells tested,
and some of them did not show any significant changes
(five out of seven cells tested for 0.07 mM, and two out of
nine cells tested for 7 mM). In the cells in which the peptide
produced an effect, the average holding current showed
a significant increase over the control current measured in
the absence of the peptide. The mean current increase induced
by 7 mM concentration of Arg-9, expressed as a percentage of
the control current, is 126%5 45% (n¼ 7). We also observed
that Arg-9 induced instantaneous current jumps like the ones
shown in Fig. 5 b. A similar behavior could also be observed
at other membrane potentials (data not shown).
It is known that acidification of the extracellular medium
can destabilize phospholipid bilayers, thereby enhancing
the destabilizing effects induced by the peptide on the plasma
membrane. Therefore, we tested the peptide’s effect on
the holding current at 50 mV in an acid bath solution
(pH ¼ 5.5). Under this condition we tested nine HUA
smooth muscle cells, and in six of them the current increased
to a much greater extent than at the physiological pH of 7.4.
The mean current increase (Fig. 5, c and d) was in this case
460% 5 130% (averaged over six experiments).
Cell-attached and inside-out: local cell
permeabilization
We next tested the effect of Arg-9 on cells in the cell-
attached and inside-out configurations. These configurations
allowed us to measure the currents induced by the peptide inBiophysical Journal 97(7) 1917–1925
1922 Herce et al.FIGURE 5 (a) Time course of the increase of the inward
membrane current after the addition of 7 mM of Arg-9 to
the extracellular solution in the whole-cell configuration
in the case of HUA smooth muscle cells. (b) Three typical
recordings of this current (pH 7.4), corresponding to the
points i, ii, and iii indicated in a and c. If the pH of the
bath solution is lowered to 5.5, the increase in the inward
current is more prominent. (d) Three typical recordings
of this current, corresponding to the points i, ii, and iii indi-
cated in c.membrane areas that are small compared to the whole
surface of the cell.
In Fig. 6 we can observe several recordings of the current
evoked by a concentration of 7 mM of Arg-9 in the pipette at
different times after the seal was obtained in HUA smooth
muscle cells. A concentration of 0.07 mM of the peptide
was also tested (data not shown), with similar results.
In the majority of tested HUA smooth muscle cells, after
periods of time ranging from 10 to 35 min, we began to
observe rapidly fluctuating current jumps that resembled
the ones we previously observed in artificial phospholipid
bilayers. These signals do not follow a repetitive pattern
and are difficult to characterize by the typical parameters
used to study ionic channels, such as mean current ampli-
tude, open probability, or dwell times. Instead, they resemble
the current patterns observed on perturbed membranes of
different kinds of cells exposed to mechanical stress
(43,44) or in cardiac cells stimulated by photosensitizer-
generated reactive oxygen species (45). This characteristic
signal can be observed in six out of seven cells obtained
from different samples of umbilical cords, although the effect
of the peptide is variable in magnitude. We also observed
similar rapidly fluctuating current jumps in some of our
control cells (without peptide in the pipette), albeit with
a much lower frequency of appearance than in the presence
of Arg-9. Cell-attached experiments with the peptide
(0.07 mM) were also made in UMR106 osteosarcoma cells
with similar results.
Fig. 7 shows current snapshots that compare the evolution
of current with time for osteosarcoma, HUA smooth muscle
cells, and phospholipid bilayers. It can be seen that in everyBiophysical Journal 97(7) 1917–1925case the ionic currents observed demonstrate a time-
increasing, rapidly fluctuating behavior. In the case of the
phospholipid bilayer, a stepwise current can also be seen
FIGURE 6 Typical cell-attached recordings of the current evoked by the
peptide placed inside the pipette in HUA smooth muscle cells at different
times after the seal was obtained.
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However, if the peptides produce discrete jumps in the cells,
these would not be easily distinguished from those belonging
to the ion channels already present in the cells. Hence, to mini-
mize the activation of voltage-operated channels, we tested
the effects of the peptide using a50 mV membrane potential
at which, in these kinds of cells, most of these voltage-oper-
ated ionic channels present a low open probability.
In the inside-out configuration, a micrometer portion of
the cell surface was covered by the tip of the glass pipette;
it was then was pulled out and only a small piece of the
membrane remained in contact with the pipette. In this
configuration, the internal surface of the cell membrane
was exposed to the bath solution. EGTA (1 mM), a calcium
chelator, was used to inhibit the activity of calcium-depen-
dent ionic channels. As in the case of the cell-attached
configuration, the recordings were obtained in a symmetric
high-potassium saline solution. When a transmembrane
potential of 50 mV (outside positive) was applied, a stable
holding current appeared. Immediately after the addition of
Arg-9 to a concentration of 7 mM to the bath solution
(now in contact with the intracellular side of the membrane),
the negative net current measured at 50 mV significantly
changed reaching more positive current values (Dcurrent ¼
75 5 18 pA, n ¼ 13). After that, we again observed the
occurrence of rapidly fluctuating, unstable, variable current
FIGURE 7 Snapshots of typical recordings of the current evoked by the
peptide (placed inside the pipette) at different times after the seal was
obtained in the cell-attached configuration in (a) an osteosarcoma cell, (b)
an HUA smooth muscle cell, and (c) a phospholipid bilayer. It can be
seen that as the time increases, the membrane is increasingly permeabilized,
and the signal reflects a rapidly fluctuating current in every case.jumps, such as those observed in the last part of the recording
shown in Fig. 8. These two kinds of behaviors were seen
only in the presence of Arg-9 and were similar in all 13 cells
tested. They were not observed in the control inside-out
patches. The peptide effect seems to have two phases in
this patch-clamp configuration: an immediate improvement
of seal resistance, followed by an increase of the patch noise,
reflecting the destabilizing effect observed in the other
configurations. This could be partially explained by the
observations made by Chico et al. (46), who reported that
significant amounts of poly-D-Arg are retained by plastic
and glass surfaces. This finding could explain our results,
because Arg-9 would be able to improve the seal by
increasing the interaction between the cell membrane and
the glass pipette, which is the base of the establishment of
a high-resistance seal. This effect does not exclude the fact
that Arg-9 can then penetrate by destabilizing the cell
membrane, as can be inferred by the occurrence of the typical
noisy currents, even though the effective peptide concentra-
tion is much less than the 7 mM that is the initial peptide
concentration.
CONCLUSIONS
We have shown experimentally that Arg-9 peptides destabi-
lize and permeabilize planar phospholipid bilayers and cell
membranes, consistent with our theoretical model.
We performed an MD simulation of Arg-9 that reproduces
the main steps for translocation previously observed for the
FIGURE 8 Typical recording of Arg-9 effects in an inside-out patch
obtained from an HUA smooth muscle cell in symmetrical ionic conditions.
(a) A recording showing the current measured at 50 mV (outside negative)
and its decrease induced by the Arg-9 addition at a concentration of 7 mM.
After a few minutes, the current trace becomes rapidly fluctuating in the
presence of the peptide. The variability of these current jumps can be
observed in the three traces of panel b extracted at different time intervals.Biophysical Journal 97(7) 1917–1925
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bilayer, attracted by the phosphate groups of the phospho-
lipids. The interactions produce large local distortions to
the phospholipid bilayer in comparison with its resting struc-
ture, and reduce the free-energy barrier as an Arg side chain
translocates attracted by phosphate groups on the distal side.
This helps the nucleation and the formation of a toroidal
pore. Once the pore is formed, the peptides translocate by
diffusing on the surface of the pore. The simulations high-
light the central role of the Arg side chains in accordance
with experimental evidence (47) showing that six or more
guanidinium groups are required to efficiently penetrate the
cell membranes.
Despite intense research, the details of the cell penetration
mechanism of poly-Arg peptides are still under discussion.
Futaki and co-workers (48) recently reviewed the subject
and concluded that proteoglycans may play a crucial role
as primary receptors for peptide internalization, and that
both endocytosis and direct membrane translocation are
possible entry routes for Arg-rich peptides. Still, some of
the most important points that remain to be determined are
whether the process is dependent on cell metabolic energy,
and whether it requires vesicle formation (i.e., endocytosis
(49) and macropinocytosis (50), among others). There is
experimental evidence that the uptake of poly-Arg can be
inhibited by blocking the cell metabolism with sodium azide
(47), lowering the temperature to 4C (51), or using macro-
pinocytosis and endocytosis inhibitors (11,50,52). However,
other reports suggest that cell penetration is independent
of metabolic cell energy. For example, knocking down
clathrin-mediated and caveolin-mediated endocytosis (53)
does not affect the ability of Tat to enter cells. The results
presented here can explain the observations of direct translo-
cation of the peptides through a mechanism that is indepen-
dent of metabolic cell energy.
Our theoretical observations show that Arg-9 is able to
nucleate transient pores that would allow ions to flow across
it. Therefore, applying an electrostatic potential across the
bilayer should induce a net ionic current that could be
detected experimentally. We confirmed this prediction by
measuring currents across planar phospholipid bilayers and
both cultured and freshly isolated mammalian cells.
The electrostatic attraction between the Arg amino acids
and the phosphate groups of the membrane is a pivotal
step in the translocation model. Therefore, different ions
would have a strong effect on the translocation of these
peptides if they were able to screen these interactions. If
the CaCl2 concentration is increased after addition of the
peptides, the permeabilization initiated by Arg-9 will be
strongly reduced. We speculate that calcium ions may be
competing for the phosphate groups, thereby reducing the
binding of the peptides to the surface of the membrane.
We have demonstrated, using theoretical and experimental
methods, that a peptide made up entirely of Arg residues is
able to interact and permeabilize biological membranes.Biophysical Journal 97(7) 1917–1925Furthermore, we have shown that the length of the side chains,
and the guanidinium group and ions present can have
a profound effect on the ability of these peptides to cross the
membrane. Understanding the mechanism by which CPPs
disrupt the plasma membrane will contribute to our funda-
mental knowledge of the mechanisms behind internalization
of charged molecules through lipid membranes, and the
design of more efficient cargo-carrying molecules, which
could lead to better drug-delivery candidates.
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